PHARMA MAR, S.A. The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 08/11/2017 19:31 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Pharma Mar announces CHMP negative trend vote in relation to Aplidin Marketing Authorization Application for multiple myeloma. Register number: 258359
